Synthetic Malarial drug -- A Trump card to kick Deadly Malaria out of sight...

Malaria awareness

Malaria is  a fatal disease that is responsible for so many deaths in the world.Though there is a approved treatment available for malaria, the malaria drugs are obtained naturally from plants. Due to fluctuations in the climatic conditions of the earth  the supply of this drug is not consistent. This created a big void between supply and demand which took away many lives. There is an estimate that Malaria sickens millions of people each year, killing at least 650,000 annually, mostly children. This made biologists think about synthetic ways to produce malaria drug. 

For the first time, researchers have successfully engineered a strain of baker’s yeast capable of supplying  malaria drugs on an industrial scale.The French pharmaceutical giant Sanofi has already begun brewing the microbes and announced plans to generate 70 million doses this year.The advance is the result of a 10-year odyssey in synthetic biology, the wholesale engineering of an organism’s genetic and metabolic system for practical purposes. 
    “This is the first synthetic biology project that has been scaled up to industrial manufacturing and will have a real impact in the world,” says Jack Newman, chief scientific officer at Amyris. “There should never been a shortage of artemisinin ever again.”